Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Brain Neoplasms 12Cognitive Dysfunction 4Radiation Injuries 3Neoplasms 3Multiple Myeloma 3Glioma 3Breast Neoplasms 3Lymphoma, B-Cell 2Lymphoma 2Glioblastoma 2Fatigue 2Colorectal Neoplasms 2Astrocytoma 2Triple Negative Breast Neoplasms 1Stroke 1Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Osteosarcoma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Meningioma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Rituximab 416Cyclophosphamide 348Vincristine 173Prednisone 172Doxorubicin 168Etoposide 160Peripheral Blood Stem Cell Transplantation 114Filgrastim 108Lenalidomide 97fludarabine phosphate 96Radiotherapy 80Cytarabine 80Gemcitabine 73Melphalan 66Mycophenolic Acid 64Cyclosporine 60Methotrexate 59Busulfan 57Ifosfamide 55Carmustine 55fludarabine 50Tacrolimus 50Whole-Body Irradiation 49Carboplatin 49polatuzumab vedotin 44Oxaliplatin 44Dexamethasone 44Antilymphocyte Serum 42ibrutinib 40Bendamustine Hydrochloride 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Neuropsychological Tests × Clear all
NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡